You have been chosen to receive this valuable information.
 
A SPECIAL
ANNOUNCEMENT FROM:
   PE Logo  
FREE WEBINAR
Using Big Data Like Biomarkers to Advance Clinical Development & Commercialization

shutterstock_447406066_250px.jpg

Wednesday, March 28, 2-3pm Register

 

What if you could use predictive models like biomarkers to pre-emptively screen and more effectively target patients who are more likely to respond to your drug in trials and in practice? 

What if you could rapidly answer questions on comparative treatment outcomes and predict those most likely to have an adverse event? 

The convergence of AI and big data enable the ability to measure, predict and personalize care in a way previously not possible. 

Join Dr. Richard Gliklich, CEO of OM1, as he explores different ways you can use big data and AI to advance drug development and commercialization, including: 

  • Identifying under-diagnosed patients 

  • Identifying likely responders in trials and in practice 

  • Predicting which patients have the most potential for adverse events 

  • Comparing and predicting treatment outcomes across different populations
Register
Message above is a paid advertisement. Content is provided by the sponsor. You received this email because you are a customer of Pharmaceutical Executive, a UBM publication. You are on the mailing list as %%emailaddress%%.